| 1 |
Middleton BF, Danchin M, Fathima P, Bines JE, Macartney K, Snelling TL. Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021. Vaccine 2023;41:636-48. [PMID: 36529591 DOI: 10.1016/j.vaccine.2022.12.008] [Reference Citation Analysis]
|
| 2 |
Fathima P, Jones MA, Moore HC, Blyth CC, Gibbs RA, Snelling TL. Impact of Rotavirus Vaccines on Gastroenteritis Hospitalizations in Western Australia: A Time-series Analysis. J Epidemiol 2021;31:480-6. [PMID: 32801278 DOI: 10.2188/jea.JE20200066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
López-Lacort M, Orrico-Sánchez A, Martínez-Beneito MÁ, Muñoz-Quiles C, Díez-Domingo J. Spatio-temporal impact of self-financed rotavirus vaccination on rotavirus and acute gastroenteritis hospitalisations in the Valencia region, Spain. BMC Infect Dis 2020;20:656. [PMID: 32894071 DOI: 10.1186/s12879-020-05373-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 4 |
Moa AM, Muscatello DJ, Turner RM, MacIntyre CR. Estimated hospitalisations attributable to seasonal and pandemic influenza in Australia: 2001- 2013. PLoS One 2020;15:e0230705. [PMID: 32282849 DOI: 10.1371/journal.pone.0230705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 5 |
Sunderland N, Westbrook J, Urwin R, Knights Z, Taitz J, Williams H, Wiles LK, Molloy C, Hibbert P, Ting HP, Churruca K, Arnolda G, Braithwaite J; CareTrack Kids investigative team. Appropriate management of acute gastroenteritis in Australian children: A population-based study. PLoS One 2019;14:e0224681. [PMID: 31697706 DOI: 10.1371/journal.pone.0224681] [Reference Citation Analysis]
|
| 6 |
Doll MK, Quach C, Buckeridge DL. Evaluation of the Impact of a Rotavirus Vaccine Program on Pediatric Acute Gastroenteritis Hospitalizations: Estimating the Overall Effect Attributable to the Program as a Whole and as a Per-Unit Change in Rotavirus Vaccine Coverage. Am J Epidemiol 2018;187:2029-37. [PMID: 29757352 DOI: 10.1093/aje/kwy097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 7 |
Wu Y, Marsh JA, McBryde ES, Snelling TL. The influence of incomplete case ascertainment on measures of vaccine efficacy. Vaccine 2018;36:2946-52. [PMID: 29699788 DOI: 10.1016/j.vaccine.2018.04.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 8 |
Reyes JF, Wood JG, Beutels P, Macartney K, McIntyre P, Menzies R, Mealing N, Newall AT. Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine 2017;35:345-52. [PMID: 27916411 DOI: 10.1016/j.vaccine.2016.11.056] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Orrico-Sanchez A, López-Lacort M, Pérez-Vilar S, Díez-Domingo J. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain. BMC Infect Dis 2017;17:267. [PMID: 28399824 DOI: 10.1186/s12879-017-2380-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Muhsen K, Kassem E, Rubenstein U, Goren S, Ephros M, Cohen D, Shulman LM. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel. Vaccine 2016;34:5916-22. [PMID: 27771186 DOI: 10.1016/j.vaccine.2016.10.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 11 |
Paulo RLP, Rodrigues ABD, Machado BM, Gilio AE. The impact of rotavirus vaccination on emergency department visits and hospital admissions for acute diarrhea in children under 5 years. Rev Assoc Med Bras 2016;62:506-12. [DOI: 10.1590/1806-9282.62.06.506] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 12 |
Mealing N, Hayen A, Newall AT. Assessing the impact of vaccination programmes on burden of disease: Underlying complexities and statistical methods. Vaccine 2016;34:3022-9. [PMID: 27156635 DOI: 10.1016/j.vaccine.2016.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 13 |
Comeau JL, Gagneur A, Quach C. Impact of a publicly funded monovalent rotavirus vaccination program in the Province of Quebec (Canada). Vaccine 2016;34:893-8. [PMID: 26795368 DOI: 10.1016/j.vaccine.2016.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 14 |
Bawa Z, Elliot AJ, Morbey RA, Ladhani S, Cunliffe NA, O'brien SJ, Regan M, Smith GE. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance. Clinical Infectious Diseases 2015;61:77-85. [DOI: 10.1093/cid/civ264] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
|
